Can B Corp.
General ticker "CANB" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.4M (TTM average)
Can B Corp. does not follow the US Stock Market performance with the rate: -24.4%.
Estimated limits based on current volatility of 13.1%: low 0.01$, high 0.02$
Factors to consider:
- Total employees count: 12 (-40.0%) as of 2023
- Top business risk factors: Going concern, FDA sanctions, Enforcement actions, Regulatory and compliance, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.00$, 0.04$]
- 2024-12-30 to 2025-12-30 estimated range: [0.00$, 0.02$]
Financial Metrics affecting the CANB estimates:
- Negative: with PPE of -0.0 at the end of fiscal year the price was very high
- Negative: Shareholder equity ratio, % of -9.89 <= 19.77
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -299.59 <= 0.85
- Positive: Industry inventory ratio change (median), % of -2.88 <= -0.21
Short-term CANB quotes
Long-term CANB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6.69MM | $2.16MM | $0.00MM |
| Operating Expenses | $20.85MM | $9.64MM | $4.76MM |
| Operating Income | $-14.17MM | $-7.49MM | $-4.76MM |
| Non-Operating Income | $-0.76MM | $-2.24MM | $-5.02MM |
| Interest Expense | $0.90MM | $2.51MM | $1.78MM |
| Income(Loss) | $-14.92MM | $-9.73MM | $-9.78MM |
| Taxes | $0.00MM | $0.01MM | $-0.00MM |
| Profit(Loss)* | $-14.92MM | $-9.74MM | $-10.20MM |
| Stockholders Equity | $2.70MM | $-1.00MM | $-12.72MM |
| Inventory | $2.02MM | $1.62MM | $0.00MM |
| Assets | $15.56MM | $10.13MM | $0.30MM |
| Operating Cash Flow | $-3.95MM | $-1.30MM | $-0.22MM |
| Capital expenditure | $0.00MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.08MM | $0.23MM |
| Financing Cash Flow | $3.57MM | $1.35MM | $-0.03MM |
| Earnings Per Share** | $-4.18 | $-0.77 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.